Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants

S. El-Sahrigy, M. Abdel-Aziz, A. Hamed (Cairo, Egypt)

Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Session: Respiratory disorders in paediatric intensive care unit
Session type: E-Communication Session
Number: 473
Disease area: Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. El-Sahrigy, M. Abdel-Aziz, A. Hamed (Cairo, Egypt). Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants. Eur Respir J 2008; 32: Suppl. 52, 473

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteinomics and ARDS
Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside
Year: 2007


Corticosteroids and acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


TGF-β inhibits alveolar fluid reabsorption: a role in ARDS?
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007


Acute respiratory distress in infants and young children [respiratory distress syndrome (RDS), acute RDS (ARDS), and bronchiolotis]
Source: International Congress 2014 – Noninvasive respiratory support for infants and young children
Year: 2014



KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004



Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012


Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


An animal model of the acute respiratory distress syndrome (ARDS)
Source: Eur Respir J 2002; 20: Suppl. 38, 486s
Year: 2002

What has been learnt from P/V curves in patients with acute lung injury/acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 22S-26S
Year: 2003



Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007


Clinico-pathological analysis of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012

Surfactant metabolism and replacement in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=119
Year: 2002

COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021

Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS)
Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Year: 2021



Recruitment manoeuvres in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 37S-42S
Year: 2003



Mechanisms of acute lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005

Eosinophilic pneumonia (acute, chronic)
Source: Respipedia Article
Year: 2017